# Efficacy and Safety of First-line ART With BIC/FTC/TAF Introduced at the First Clinical Visit

> **NCT06518213** · — · COMPLETED · sponsor: **University Hospital for Infectious Diseases, Croatia** · enrollment: 112 (actual)

## Conditions studied

- HIV Infections

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06518213
- **Lead sponsor:** University Hospital for Infectious Diseases, Croatia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-01
- **Primary completion:** 2022-12-31
- **Final completion:** 2024-03-31
- **Target enrollment:** 112 (ACTUAL)
- **Last updated:** 2024-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06518213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06518213, "Efficacy and Safety of First-line ART With BIC/FTC/TAF Introduced at the First Clinical Visit". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06518213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*